IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis

American Journal of Surgical Pathology

Volumn 34, Issue 1, 2010, Pages 88-94

  Zhang, Lizhi ^a   Lewis, Jason T ^a   Abraham, Susan C ^b   Smyrk, Thomas C ^a   Leung, Stanley ^a   Chari, Suresh T ^a   Poterucha, John J ^a   Rosen, Charles B ^c   Lohse, Christine M ^a   Katzmann, Jerry A ^a   Wu, Tsung Teh ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Transplant Center   (United States)

Author keywords

IgG4; IgG4 associated cholangitis; Immunohistochemistry; Liver transplant; Primary sclerosing cholangitis

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER TRANSPLANTATION; METABOLISM; PATHOLOGY; PLASMA CELL; SCLEROSING CHOLANGITIS;

CHOLANGITIS, SCLEROSING; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; PLASMA CELLS;

EID: 73949086188     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181c6c09a     Document Type: Article

References (22)

1. Boberg KM, Egeland T, Schrumpf E. Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients. Scand J Gastroenterol. 2003;38:991-995.
2. Erkelens GW, Vleggaar FP, Lesterhuis W, et al. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet. 1999; 354:43-44.
3. Esposito I, Born D, Bergmann F, et al. Autoimmune pancreato-cholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis. PLoS ONE. 2008;3:e2539.
4. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646-1653.
5. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715.
6. Ichimura T, Kondo S, Ambo Y, et al. Primary sclerosing cholangitis associated with autoimmune pancreatitis. Hepatogastroenterology. 2002;49:1221-1224.
7. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003; 38:982-984.
8. Kawa S, Hamano H, Umemura T, et al. Sclerosing cholangitis associated with autoimmune pancreatitis. Hepatol Res. 2007;37 (suppl 3):S487-S495.
9. Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol. 1991;22:387-395.
10. Kojima E, Kimura K, Noda Y, et al. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol. 2003;38:603-607.
11. Lewis JT, Talwalkar JA, Rosen CB, et al. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Am J Surg Pathol. 2007;31:907-913.
12. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070-2075.
13. Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology. 2001;48:625-630.
14. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20-25.
15. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas. 2005;30:76-82.
16. Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol. 2007;42:550-559.
17. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinico-pathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119-1127.
18. Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas. 2005;31: 232-237.
19. Parkes M, Booth JC, Pillai G, et al. Do steroids help jaundice caused by primary sclerosing cholangitis? J Clin Gastroenterol. 2001;33:319-322.
20. Schramm C, Schirmacher P, Helmreich-Becker I, et al. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series. Ann Intern Med. 1999;131:943-946.
21. Vlug A, Nieuwenhuys EJ, van Eijk RV, et al. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin (Paris). 1994;52:561-567.
22. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23-28.